Moslosooflavone protects against brain injury induced by hypobaric hypoxic via suppressing oxidative stress, neuroinflammation, energy metabolism disorder, and apoptosis
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgad109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Jie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Brain Injuries. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Military Logistic Support Capability Enhancement, Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
Objectives
To investigate the protect effect of moslosooflavone against brain injury induced by hypobaric hypoxia (HH) in mice.
Methods
Protective effects of moslosooflavone in oxidative stress, neuroinflammation, energy metabolism disorder, and apoptosis were studied in HH-induced brain damage mice. The pathological morphology in the cortex of mice was determined by hematoxylin and eosin staining. The related protein expressions were detected by western blot. Key findings Moslosooflavone improved HH-induced brain histopathological changes, reduced the contents of ROS and MDA, and elevated the levels of antioxidant enzymes and GSH in HH-exposed brains of mice. Moslosooflavone also markedly enhanced the ATPase activities and PK, ATP contents, while reducing LDH activity and the LD, TNF-α, IL-1β, and IL-6 contents HH-exposed brains of mice. In addition, moslosooflavone notably decreased the expression of HIF-1α, VEGF, Bax, and cleaved caspase-3 dramatically increasing the expression of Bcl-2, Nrf2, and HO‑1 in HH-exposed brains of mice.
Conclusions
Our current studies indicate that moslosooflavone protects HH-induced brain injury possibly through alleviating oxidative stress and neuroinflammation, maintaining the balance of energy metabolism, and inhibiting cell apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
- Department of Pharmacy, The 940th Hospital of Joint Logistics Support Force of PLA, Lanzhou, Gansu 730050, China.
- Department of Pharmacy, Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu 730050, China.
ORCID-Profile: Linlin Jing
Förderung
- National Natural Science Foundation of China
- Military Logistic Support Capability Enhancement
- Natural Science Foundation of Gansu Province
- Institutional Foundation
- Xi'an Jiaotong University
- Xi’an Jiaotong University
Zitieren
APA
Zhang, J., Zhao, T., Zhang, P., Shi, Z., Da, Q., Ma, H., & Jing, L. (2024). Moslosooflavone protects against brain injury induced by hypobaric hypoxic via suppressing oxidative stress, neuroinflammation, energy metabolism disorder, and apoptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad109
Vancouver
Zhang J, Zhao T, Zhang P, Shi Z, Da Q, Ma H, et al. Moslosooflavone protects against brain injury induced by hypobaric hypoxic via suppressing oxidative stress, neuroinflammation, energy metabolism disorder, and apoptosis. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad109
BibTeX
@article{Zhang2024,
author = {Zhang, Jie and Zhao, Tong and Zhang, Pengpeng and Shi, Zhiqun and Da, Qingyue and Ma, Huiping and Jing, Linlin},
title = {Moslosooflavone protects against brain injury induced by hypobaric hypoxic via suppressing oxidative stress, neuroinflammation, energy metabolism disorder, and apoptosis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgad109}
}
EUVIMED